MAAT PHARMA ANNOUNCES POSITIVE PHASE 1B RESULTS, MEETING PRIMARY ENDPOINT IN THE EVALUATION OF MAAT033 IN AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Reuters · 11/26 06:30

Please log in to view news